LXA4 inhibited TGF-β-mediated transformation in PSCs by blocking pSmad2/3 signaling, restricted crosstalk between CAF and PDAC cells and inhibited tumor growth, attributed to a significant reduction in fibrosis in a PDAC mouse model [149]. The gene discussed is TGFB1; the disease is neoplasm.